These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36376130)

  • 21. Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects.
    Wu J; Xu H; Li H; Ma L; Chen J; Yuan F; Sheng L; Liu C; Chen W; Li X
    Drug Des Devel Ther; 2023; 17():761-769. PubMed ID: 36925997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of food on the pharmacokinetics of ponatinib in healthy subjects.
    Narasimhan NI; Dorer DJ; Niland K; Haluska F; Sonnichsen D
    J Clin Pharm Ther; 2013 Dec; 38(6):440-4. PubMed ID: 23888935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of meal timing on pharmacokinetics and pharmacodynamics of tegoprazan in healthy male volunteers.
    Yoon DY; Sunwoo J; Shin N; Kim AR; Kim B; Song GS; Jang IJ; Lee S
    Clin Transl Sci; 2021 May; 14(3):934-941. PubMed ID: 33382926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Pharmacokinetic Profile of Palovarotene: An Open-Label Phase I Trial Investigating the Effect of Food and Potential for Drug-Drug Interaction in Healthy Participants.
    Marino R; Dube L; Ogier J; Le Quan Sang KH
    Eur J Drug Metab Pharmacokinet; 2023 Nov; 48(6):691-707. PubMed ID: 37804430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of food on the pharmacokinetics of clozapine orally disintegrating tablet 12.5 mg: a randomized, open-label, crossover study in healthy male subjects.
    Disanto AR; Golden G
    Clin Drug Investig; 2009; 29(8):539-49. PubMed ID: 19591515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a high-fat meal on the relative bioavailability of H3B-6527, a novel FGFR4 inhibitor, in healthy volunteers.
    Rioux N; Kim A; Nix D; Bowser T; Warmuth M; Smith PG; Schindler J
    Cancer Chemother Pharmacol; 2019 Jan; 83(1):91-96. PubMed ID: 30368584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Phase I, Randomized, Crossover, Open-label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food.
    Zomorodi K; Kankam M; Lu Y
    Clin Ther; 2019 Feb; 41(2):196-204. PubMed ID: 30598342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects.
    Shimizu H; Nishimura Y; Shiide Y; Yoshida K; Hirai M; Matsuda M; Nakamaru Y; Kato Y; Kondo K
    Clin Pharmacol Drug Dev; 2021 Oct; 10(10):1188-1197. PubMed ID: 33955162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1).
    Aslanis V; Abd-Elaziz K; Slack RJ; Brinch A; Gravelle L; Morley W; Phung D; Herman K; Holyer I; Poulsen KK; Dogterom P; Tantawi S; Zetterberg FR; Jacoby B; Schambye H; Lindmark B
    Cancer Chemother Pharmacol; 2024 Nov; 94(5):707-720. PubMed ID: 39167148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the Pharmacokinetics of the Phase II and Phase III Capsule Formulations of Selumetinib and the Effects of Food on Exposure: Results From Two Randomized Crossover Trials in Healthy Male Subjects.
    Tomkinson H; McBride E; Martin P; Lisbon E; Dymond AW; Cantarini M; So K; Holt D
    Clin Ther; 2017 Nov; 39(11):2260-2275.e1. PubMed ID: 28985960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of High-Fat Meal on the Pharmacokinetics and Safety of Valsartan/Amlodipine Fixed Dose Combination Tablets in Healthy Subjects.
    Song H; Qiu B; Sun X; Guo C; Hu Y; Bai W; Dong Z
    Drug Des Devel Ther; 2024; 18():43-51. PubMed ID: 38225972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Food on the Pharmacokinetic and Pharmacodynamic Profiles of Hetrombopag in Healthy Volunteers.
    Wang Z; Chen X; Li A; Chen L; Wang Y; Zheng L
    Clin Ther; 2020 Dec; 42(12):2280-2288. PubMed ID: 33109386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative bioavailability and the effect of meal type and timing on the pharmacokinetics of migalastat in healthy volunteers.
    Johnson FK; Mudd PN; Janmohamed SG
    Clin Pharmacol Drug Dev; 2015; 4(3):193-202. PubMed ID: 27140799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Differential Food Patterns on the Pharmacokinetics of Enteric-Coated Mesalazine Tablets in the Same Cohort of Healthy Chinese Volunteers.
    Zhang SH; Li Y; Wei SS; Guo L; Huang XM; Chen Y; Wu XX; Cai HL; Zhang BK
    Clin Pharmacol Drug Dev; 2020 Jan; 9(1):41-49. PubMed ID: 31056855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of food and acid-reducing agents on the pharmacokinetic profile of capivasertib: Results from a randomized, crossover study.
    Miller C; Sommavilla R; Murphy D; Morris T; Khatun M; Cullberg M
    Br J Clin Pharmacol; 2023 Nov; 89(11):3330-3339. PubMed ID: 37328269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of Mirabegron, a β3-Adrenoceptor Agonist for Treatment of Overactive Bladder, in Healthy East Asian Subjects.
    Iitsuka H; van Gelderen M; Katashima M; Takusagawa S; Sawamoto T
    Clin Ther; 2015 May; 37(5):1031-44. PubMed ID: 25791612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials.
    Godfrey AR; Digiacinto J; Davis MW
    Clin Ther; 2011 Jun; 33(6):766-75. PubMed ID: 21704241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, phase I, 3-way crossover study to examine the effects of food on the pharmacokinetics of single doses of 400 mg posaconazole oral suspension in healthy male Taiwanese subjects.
    Lin TY; Yang MH; Chang FY
    Ther Drug Monit; 2013 Apr; 35(2):223-7. PubMed ID: 23503449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is it appropriate regarding patient preference to take Myrtol standardized enteric-coated soft capsules after a meal rather than at fasted state? A food-drug pharmacokinetic interaction study in healthy Chinese volunteers.
    Zhao TT; Zhu LL; Chen M; Zhou Q
    Patient Prefer Adherence; 2016; 10():2031-2037. PubMed ID: 27757023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.